Searchable abstracts of presentations at key conferences on calcified tissues

ba0005p410 | Osteoporosis: treatment | ECTS2016

Can bone turnover markers help to define the duration of bisphosphonate drug holidays?

Statham Louise , Aspray Terry , Abdy Sharon

Background: On cessation of bisphosphonate treatment, while bone mineral density decreases slowly, bone resorptive markers such as C-terminal telopeptide (CTX) increase more quickly and may be useful in monitoring ‘offset’ of action. Our aim was to analyse changes in CTX on stopping long-term bisphosphonate treatment to guide clinical decision-making on the duration of treatment cessation (‘drug holidays’).Subjects and methods: A tota...

ba0005p229 | Energy metabolism and bone, fat and bone | ECTS2016

Impaired adipose tissue inflammation results in increased bone mineral density in mice

Grahnemo Louise , Gustafsson Karin , Asterholm Wernstedt Ingrid , Lagerquist Marie

Obesity, diabetes, and high fracture risk is linked, but the mechanism is unclear. However, impaired acute adipose tissue inflammation may be a common denominator for these conditions. Impaired adipose tissue inflammation leads to low adipogenesis, insufficient adipose expansion, and signs of diabetes.The aim of this study was to investigate if the low adipogenesis induced by impaired adipose tissue inflammation is coupled to increased osteoblastogenesis...

ba0001pp349 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Women with hormone sensitive breast cancer who have received chemotherapy including prednisolone have reduced bone mass

Ronn Sofie , Hald Jannie D , Thisted Marianne , Andersen Louise , Gronhoj Louise , Jensen Anders Bonde , Langdahl Bente L

Introduction: Aromatase inhibitors (AI) used as adjuvant treatment of hormone-sensitive breast cancer reduce the level of circulating estrogen and cause accelerated bone loss. The aim of this study is to investigate the prevalence of osteoporosis in women with breast cancer and the effect of chemotherapy on the risk of osteoporosis.Methods: Three hundred and sixty women with hormone-sensitive breast cancer who were scheduled to start treatment with AI we...

ba0003pp392 | Other diseases of bone and mineral metabolism | ECTS2014

Serum concentration of bone tissue metabolism markers in 28 and 180-day-old Polish Large White pigs

Beveridge Louise , Struthers Allan , Khan Faisel , Jorde Rolf , Scragg Robert , MacDonald Helen , Witham Miles

Evaluation of time-related changes of serum biochemical bone metabolism markers was performed in male pigs. Control group (n=7) received saline. NanoCa group (n=7) received nanopartical calcium per os (Ace Nano Calcium, NanoTechWorld, Korea). Dex group (n=7) received dexamethasone (1 mg/kg/48 hr i.m.). NanoCa/Dex group (n=6) received simultaneously nanopartical calcium and dexamethasone the same as the groups NanoCa and Dex...

ba0005p91 | Calciotropic and phosphotropic hormones and mineral metabolism | ECTS2016

PTH and vitamin D in Inuit and non-Inuit in Greenland

Andersen Stig , Schaebel Louise K. , Heickendorf Lene , Mosekilde Leif , Laurberg Peter

Background: Sun exposure may be limited in Arctic populations and Greenland Inuit have adapted to the Arctic environment. The influence of chronic low vitamin D level on PTH to uphold a normal serum calcium remains to be elucidated.Objective: To describe the association between PTH and factors known to influence PTH-, including vitamin D (25OHD) and calcium, in Arctic populations.Methods: Inuit and non-Inuit in the capital city Nuu...

ba0005p275 | Nutrition | ECTS2016

Vitamin D from the marine inuit diet and markers of inflammation – a population-based survey in Greenland

Schaebel Louise , Bonefeld-Jorgensen Eva , Laurberg Peter , Vestergaard Henrik , Andersen Stig

Background: The traditional Inuit diet in Greenland consists mainly of fish and marine mammals. The marine diet is an important source for vitamin D in Greenland. Vitamin D has anti-inflammatory capacity but markers of inflammation were high in Inuit with a high intake of marine food items. Yet, the effect of vitamin D on inflammation in Inuit remains unsettled.Objectives: To investigate the association between vitamin D and markers of inflammation in a ...

ba0006p126 | (1) | ICCBH2017

A case of severe reaction following the use of Bisphosphonates in a patient with Osteogenesis Imperfecta

Park Julie , Alsaffar Hussain , Apperley Louise , Bishop Nick , Dharmaraj Poonam , Ramakrishnan Renuka

Background: We present a case of unusual delayed multi-systemic reaction, following treatment with Pamidronate. The reaction, resembling rhabdomyolysis, requiring intensive care support, has not been reported previously to our knowledge.Presenting problem: An 11 month old boy with severe osteogenesis imperfecta (OI) presented with hyperpyrexia and respiratory distress 10 days after his fifth cycle of Pamidronate. He had significant derangement of his bio...

ba0006p161 | (1) | ICCBH2017

Early-life vitamin D status and bone mass at five years in a prospective birth cohort study

Chaoimh Carol ni , Murray Deirdre , Kenny Louise , Irvine Alan , Hourihane Jonathan , Kiely Mairead

Objective: We aimed to investigate associations between early-life vitamin D status, mode of infant milk-feeding and bone outcomes at five years.Methods: Participants were from the prospective mother-infant SCOPE-BASELINE Birth Cohort Study. Serum 25 hydroxyvitamin D (25(OH)D) concentrations were quantified at 15 weeks gestation, in umbilical cord sera and at two and five years using a gold-standard CDC-accredited LCMS method. Whole-body bone mineral con...

ba0005p474 | Paediatric bone disease | ECTS2016

Defining a new severity classification and searching for a pronostic factor in cherubism: NFATc1 localization is the answer

Kadlub Natacha , Siessecq Quentin , Galmiche Louise , Vazquez Marie-Paule , Badoual Cecile , Berdal Ariane , Picard Arnaud , Descroix Vianney , Coudert Amelie

Cherubism is a rare genetic disease (OMIM #118400) characterized by a massive jaw bone osteolysis. This pathology appears around 2–5 years old and in the less severe cases spontaneously regresses after puberty. So far the only treatment available is surgery, often disabling and traumatic. As the cherubism pathophysiology is not yet understood, we carried out a thoroughly characterization of the cherubism granulomas from ten unrelated patients to determine the cells involv...